RCKT
Rocket Pharmaceuticals, Inc.NASDAQHealthcare$3.46-2.54%ClosedMarket Cap: $375.6M
As of 2026-04-07
Analyst Consensus
Consensus
Hold
Target (Consensus)
$5.00
Target (Median)
$5.00
Target Range
$5.00 - $5.00
Upside from current price: 44.5%
Rating Distribution
0 Strong Buy6 Buy6 Hold1 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-30 | B of A Securities | maintain | Buy | Buy |
| 2026-03-27 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-02 | Goldman Sachs | maintain | Sell | Sell |
| 2026-02-27 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-11-18 | JP Morgan | downgrade | Underweight | Overweight |
| 2025-11-18 | B of A Securities | maintain | Buy | Buy |
| 2025-10-14 | Chardan Capital | maintain | Buy | Buy |
| 2025-10-03 | Leerink Partners | maintain | Market Perform | Market Perform |
| 2025-08-20 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-20 | B of A Securities | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.25 | $19.9M | 7 |
| Sun Dec 31 | $-0.89 | $78.9M | 6 |
| Mon Dec 31 | $-0.51 | $177.6M | 4 |
| Tue Dec 31 | $0.32 | $412.3M | 2 |